Skip to main content
Mike Ward

Mike Ward

Michael P. Ward, Senior Director of Strategy and Partnerships (formerly Head of Sales) at Firefly Neuroscience, maker of the FDA-cleared AI-powered brain health platform BNA.

Sep 27, 2026

1:09
It's now soon.
1:12
Awesome.
1:12
Yeah.
1:12
So, you know, it made complete sense to partner with Collin when we reached out a few weeks ago.
1:17
So last March, Firefly, we made a press release where we announced that we identified students EEG and ERP biomarkers where we actually can identify the difference between the inattentive type, the hyperactive arousal type, or if someone actually doesn't have ADHD and maybe just has insomnia or sleep issues, which happens quite frequently, we come to find out from many of our psychiatrists.
1:42
So we took all of our microdata and with the mind of Dave DiCaprio, who went to MIT and is a trained engineer and data scientist, and won the CMS AI challenge a few years ago, we incorporated AI into our Firefly reports that when a provider does a 20-minute EEG with Firefly, one of the first things that will pop up on that report is actually an AI analysis on the cognitive biomarker findings and what type of biomarkers a patient may or may not have indicating the type of ADHD, all of which is designed to help a provider read and interpret that report.

5 MINS LATER

7:25
please take me through.
7:26
So, no, actually, I was going to give another example.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.